SBIR/STTR Research Award

Innovative therapy for accelerated recovery of decompression sickness patients

Award identifier 8519accdcfa72c93ab441993b3d8b8290f8abb46d5dcd38cc20ec0a7062d1c77Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$150,000

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SIL Technologies LLC
Proposal award date
2018-07-01
Contract end date
2019-12-31
UEI
S9LHLCWJ6A17
Solicitation number
PA17-302
Topic code
NHLBI

Research abstract

PROJECT SUMMARY There are aroundemergency room admissions annually in the US due to scuba injuriesFrom thosearoundrelate to Decompression SicknessDCSa condition developed when nitrogen dissolved in blood and tissues at high pressure forms bubbles as pressure decreasesTreatment for DCS is recompression in hyperbaric chambersfollowing slow and controlled normalization of pressure conditionsEarly intervention is crucial once the onset of DCS symptoms are detectedhoweverit is limited to management of symptoms while quick evacuation to specialized medical facilities is arrangedSIL Technologies is proposing to open a new avenue for early treatment that will be initiated in the field by emergency respondersThe treatment will use innovative technology able to disturb the bubbles in the bloodstream splitting them into smaller ones that will dissolve expeditiouslyThanks to the proposed technologyit would be possible to prevent the worst damages created by DCS which are related to the presence of the largest bubblesMoreoverthe recovery of the patient will be drastically acceleratedThe long term objective of the research is to normalize the presence of bubbles afterminutes of treatment without further secondary effectsThe specific aims of this research effort are ito demonstrate the capability of the technology to disturb bubbles in the blood stream dividing them into smaller onesiito determine the operating requirements of the intended medical deviceiiito demonstrate hematologic integrity after treatmentand ivto estimate the duration of the treatment required for complete dissolution of Ndepending on the severity of the initial conditionsThe technology herein proposed evolves from years of basic research conducted to detect bubbles in bloodstream and tissuesIt consists of a piezoelectric transducer shaped like a ringor an array of transducers that will be placed belting the patient thighPiezoelectrics will be set to operate at its resonance frequencythereforecreating a standing acoustic wave inside the thighThe bubbles will be fragmented into smaller ones at sufficiently high amplitude of the resonant waveThe gas will then dissolve quicklysince the gas liquid surface interface is multipliedThis research combines experimental and numerical efforts in a test section consisting of fresh swine thighs where iliac and femoral vessels will be dissected and isolatedA stabilized blood circuit will be prepared using plastic infusion cords with arteries as inflow side and veins as outflowBubbles of controlled size and in a controlled number will be inserted in the blood stream and samples will be collected for analysis after passing along the tightwhere the piezoelectric transducers will be placed and set to operateExperiments will be conducted within five hours after death of the swineThe size and amount of bubbles crossing the piezoelectric will be determined following well established methods relying on terminal velocity form buoyant effectsHematological integrity will be monitored using a chemistry analyzer paying special attention to the following parametersWBCLYMPHMONOGRANHCTMCVRDWHGBMCHCMCHRBCPLTMPV and PLT size distribution histogramsDepending on the analytical resultsmicroscopy studies may be conducted to determine the existence of blood clots Project Narrative PROJECT NARRATIVE A new avenue for treatment of decompression sicknessDCSis proposedit is based on innovative acoustic research that targets the elimination of damaging nitrogen bubbles in the bloodstream using an approach different to recompression on hyperbaric chambersThe technology is expected to avoid long term effects caused by bubbles in DCS patients during their evacuation to medical providers with hyperbaric facilitiessince it can be applied by first medical respondersThe accelerated recovery provided by the technology will significantly reduce costs and hospital stay

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

3 SBIR/STTR records share this UEI (2017–2022). Reported award amounts total $525,000. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.